A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new ‘long acting’ medicine for the prevention of malaria.
Every year, malaria afflicts hundreds of millions of people and kills hundreds of thousands of children. Despite considerable success in reducing the worldwide prevalence of malaria, its incidence in visitors to endemic areas has continued to rise steadily.
Currently, the best available prevention of malaria requires oral dosing of antimalarial tablets. Chronic oral dosing of these medicines has significant complications because healthy people need to strictly adhere to the medication in order for effective prophylaxis to occur.
The study, led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, aimed to utilise nanotechnology to improve the delivery of an existing antimalarial drug via a novel injectable format that can maintain blood concentration of the drug for weeks or months following a single dose.
Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the diagnosis, prevention or treatment of disease in the human body.
Solid Drug Nanoparticles (SDNs) are a nanotechnology with favourable characteristics to enhance drug exposure and improve the treatment or prevention of several diseases, including HIV and malaria.
The Liverpool team have previously shown SDNs to be effective for oral delivery of drugs, but this is the first time they have shown benefits for a long-acting injectable (LAI) format. These particles have an approximate diameter that is 1/500th the width of a human hair, and once injected into the muscle, establish a drug depot that releases drug into the bloodstream over an extended period of time.
Through the use of this technology the trans-Atlantic research team developed an LAI version of a daily anti-malarial tablet (atovaquone) which provided prophylactic blood concentrations in mice for a period of 28 days. Moreover, mice injected with the nanomedicine were completely protected from the malaria parasite when exposed during this time, and since mice eliminate the drug much more rapidly in humans, a much longer duration of protection might be expected in people.
Impacting large numbers
Professor Rannard, said: “Although anti-malaria drugs exist they require individuals to take medication daily. Chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to preventative therapies.
“Our research seeks to remove the need for daily tablets and generate long-acting dosing technologies that may be able to provide therapeutic drug concentrations for months after a single administration. This would provide a clinically-relevant intervention that could readily impact large numbers of people and significantly prevent the transmission of malaria.”
Professor Owen, added “The ability of this nanomedicine to protect from infection by malaria may provide an additional tool in the global arsenal used to combat malaria in non-immune travellers and ultimately people who live in endemic areas of the world. Since atovaquone is already licenced for use in humans and the nanomedicine contains ingredients already used in other medicines, it could be enter clinical trials within a very short timescale”
“If other drugs can be manufactured in this way, in the longer term there is also potential for a long-acting combination therapy for malaria.”
The full study, entitled ‘Long-acting injectable atovaquone nanomedicines for malaria prophylaxis’, can be found here.
For further information about nano-medicine please listen to the University of Liverpool podcast featuring Professors Rannard and Owen which can be found here.
The Latest on: Solid Drug Nanoparticles
Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors
on April 18, 2018 at 1:08 pm
We look forward to advancing this promising therapy in gynecologic and other solid tumor cancers and plan to initiate ... a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. […]
What is nanochemistry?
on April 18, 2018 at 9:25 am
Since all of the atoms in a nanoparticle are present on the surface ... Small rods of atoms or nanowires are also of interest. These solid dense structures are built atom by atom in a controlled manner, allowing for impurity doing at for control of ... […]
Ferro Fluids Market : Latest Trends and Future Outlook : 2025
on April 17, 2018 at 12:23 am
Typically, a common Ferro fluid may contain 5% magnetic solid, 10% surfactant ... Ferro fluids find their applications in various industries such as medicine, drug targeting, cell separation, hyperthermia, and magnetic resonance imaging. […]
Global Drug and Gene Delivery Systems Market Key Insights and Opportunities Expected to Grow Till 2025
on April 16, 2018 at 9:57 am
3DP can produce solid dosage forms with multiple drugs and excipients ... Nanotechnology in the field of drug delivery is one of the advanced methods of drug delivery. Magneto-electric nanoparticles are useful for controlled drug delivery and release. […]
Tool Based on Use of Carbon Nanoparticles Enables Detection of Antidepressants in Urine Samples
on April 10, 2018 at 8:29 am
By incorporating carbon nanoparticles, the polymer properties are enhanced and ... The first is being able to determine the presence of the drug even when it has been in the sample for a long time. For instance, excretion of a drug can take between 24 ... […]
A tool based on the use of carbon nanoparticles enables detection of antidepressants in urine samples
on April 10, 2018 at 8:21 am
By incorporating carbon nanoparticles, the polymer properties are enhanced and ... The first is being able to determine the presence of the drug even when it has been in the sample for a long time. Forinstance, excretionof a drug can takebetween 24 and ... […]
Understanding Surface Enhanced Raman Spectroscopy (SERS)
on April 10, 2018 at 5:47 am
SERS is used in a variety of areas, including forensics, medical and analytical testing, trace material analysis, drug discovery ... examining ways to use nanoparticles for SERS enhancement, as well as exploring different solid roughened surfaces and ... […]
Nanoparticle drug stops cancer’s spread in mice
on January 22, 2015 at 11:55 am
Now, Dutch researchers report that they’ve packaged the drug in nanoparticles targeted ... it must target cancer cells. It is difficult for lab researchers to quickly study metastases from solid tumors, because they might have to wait for months for ... […]
Chemists design 'smart' nanoparticles to improve drug delivery, DNA self-assembly
on August 9, 2013 at 12:36 pm
chemical sensing and drug delivery and treatment—is the self-assembly of nanoparticles. During self-assembly, the chemistry attached to the nanoparticle interface drives a reaction. As a result, particles come together to form a solid, a chai or a small ... […]
Nanoparticles, 'pH phoresis' could improve cancer drug delivery
on July 10, 2013 at 5:00 am
(Phys.org) —Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate ... the delivery of drugs to cancer cells in solid tumor tissues," said You-Yeon Won, an associate ... […]
via Google News and Bing News